Fda form 4035-2026

See details

4.8 out of 5

24 votes

The document is the FDA Orphan Drug Designation Request Form, which outlines the process for sponsors to request orphan drug designation for treatments targeting rare diseases. It includes sections for providing sponsor and product information, details about the disease or condition, scientific rationale, clinical data, regulatory status, and population estimates. The form emphasizes the need for supporting documentation and specifies that the affected population must be less than 200,000 individuals in the U.S. to qualify for orphan designation.

Here's how it works

01. Edit your fda form 4035 online

Type text, add images, blackout confidential details, add comments, highlights and more.

02. Sign it in a few clicks

Draw your signature, type it, upload its image, or use your mobile device as a signature pad.

03. Share your form with others

Send form fda 4035 via email, link, or fax. You can also download it, export it or print it out.

How to use or fill out FDA Form 4035 with our platform

Ease of Setup

DocHub User Ratings on G2

Ease of Use

DocHub User Ratings on G2

Click ‘Get Form’ to open FDA Form 4035 in the editor.
Begin by entering the *Date of Request in the specified format (mm/dd/yyyy). This is a required field.
Fill in the Sponsor Contact Information, ensuring all required fields marked with an asterisk (*) are completed, including Business Name and Primary Contact Email Address.
If applicable, provide details for the Sponsor U.S. Resident Agent Information. This section is crucial for foreign sponsors.
In the Product Information section, specify whether your submission pertains to a Biologic, Combination Product, or Drug. Fill in all relevant fields including Generic/Descriptive Name.
Describe the Requested Orphan Disease or Condition clearly, indicating whether it’s for Treatment, Prevention, or Diagnosis.
Provide a detailed Description of the Disease or Condition and attach any necessary documents using the paperclip icon on the left toolbar.
Complete sections regarding Scientific Rationale and Clinical Superiority as needed, ensuring you provide supporting data where applicable.

Start filling out FDA Form 4035 today using our platform for free and streamline your submission process!

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.

How long does an orphan designation last?

The exclusivity granted to orphan drugs provides seven years without generic competition for the approved orphan designation but does not prevent generic competition for other approved uses of the medicine.

Is orphan drug designation a big deal?

Key Takeaways. Orphan drug status (designated by the FDA) gives a company exclusive marketing rights for a seven-year period, along with other benefits to recoup the costs of researching and developing drugs to treat rare diseases.

Is orphan drug designation good?

The FDA has authority to grant orphan drug designation to a drug or biological product to prevent, diagnose or treat a rare disease or condition. Orphan drug designation qualifies sponsors for incentives including: Tax credits for qualified clinical trials. Exemption from user fees.

What is the success rate of orphan drugs?

There is a great need for continued incentives for rare disease drug development, as development for rare diseases takes nearly four years longer than for non-rare disease conditions, and orphan drugs have an estimated 6% success rate in clinical trials.

Who receives the FDA Form 483?

A Form FDA 483 is issued to firm management at the conclusion of an inspection when an investigator(s) has observed conditions that in their judgment may constitute violations of the Food, Drug, and Cosmetic (FDC) Act and other Acts or regulations.

4102888150

FDA Form 4035 instructions FDA Forms Orphan drug annual Report FDA guidance Orphan drug designation FDA Form FDA 3671 Orphan drug designation application example 21 CFR 316.3 b 13 FDA orphan drug designation vs approval

Security and compliance

At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.

Learn more

How long does it take to get an orphan drug designation?

Requests for an orphan drug designation can be submitted through the FDA Form 4035. The FDA will complete a review of the orphan drug designation request within 90 days of its receipt.

Do investors value the FDA orphan drug designation?

The study finds that investors in pharmaceutical companies view the orphan designation as a signal of higher company value.

How to submit an orphan drug designation request?

Sponsors may submit orphan drug designation requests one of three ways: Through the CDER NextGen portal. By emailing the required information to orphan@fda.hhs.gov. By mailing the required information to: Office of Orphan Products Development. Attention: Orphan Drug Designation Program. Food and Drug Administration.